HIGHLIGHTS
- who: Yongmei Dai et al. from the Department of Oncology, Shengli Clinical Medical College of Fujian Medical University and Fujian Provincial Hospital, Fujian, China have published the research work: Multiomics Integrative Analysis Identifying EPC1 as a Prognostic Biomarker in Head and Neck Squamous Cell Carcinoma, in the Journal: BioMed Research International of 16/09/2022
- what: The authors aimed to provide further insight into the prognostic significance of EPC1 in patients with HNSCC and comprehensively analyze EPC1 from a multiomics perspective to explore its mechanisms.
- how: Based on a range of published public . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.